254 related articles for article (PubMed ID: 11945173)
1. Multiple activities in lantibiotics--models for the design of novel antibiotics?
Pag U; Sahl HG
Curr Pharm Des; 2002; 8(9):815-33. PubMed ID: 11945173
[TBL] [Abstract][Full Text] [Related]
2. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
3. Lantibiotics: mode of action, biosynthesis and bioengineering.
Bierbaum G; Sahl HG
Curr Pharm Biotechnol; 2009 Jan; 10(1):2-18. PubMed ID: 19149587
[TBL] [Abstract][Full Text] [Related]
4. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
Entian KD; de Vos WM
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
[TBL] [Abstract][Full Text] [Related]
5. Gene-encoded antibiotics made in bacteria.
Sahl HG
Ciba Found Symp; 1994; 186():27-42; discussion 42-53. PubMed ID: 7768156
[TBL] [Abstract][Full Text] [Related]
6. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
7. Lantibiotics: structure, biosynthesis and mode of action.
McAuliffe O; Ross RP; Hill C
FEMS Microbiol Rev; 2001 May; 25(3):285-308. PubMed ID: 11348686
[TBL] [Abstract][Full Text] [Related]
8. Combination of antibiotic mechanisms in lantibiotics.
Hoffmann A; Pag U; Wiedemann I; Sahl HG
Farmaco; 2002 Aug; 57(8):685-91. PubMed ID: 12361237
[TBL] [Abstract][Full Text] [Related]
9. Lantibiotics and microcins: polypeptides with unusual chemical diversity.
Jack RW; Jung G
Curr Opin Chem Biol; 2000 Jun; 4(3):310-7. PubMed ID: 10826980
[TBL] [Abstract][Full Text] [Related]
10. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
[TBL] [Abstract][Full Text] [Related]
11. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
Sahl HG; Jack RW; Bierbaum G
Eur J Biochem; 1995 Jun; 230(3):827-53. PubMed ID: 7601145
[TBL] [Abstract][Full Text] [Related]
14. Lantibiotics: peptides of diverse structure and function.
Willey JM; van der Donk WA
Annu Rev Microbiol; 2007; 61():477-501. PubMed ID: 17506681
[TBL] [Abstract][Full Text] [Related]
15. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Bonelli RR; Schneider T; Sahl HG; Wiedemann I
Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lantibiotic gene clusters and encoded proteins.
Siezen RJ; Kuipers OP; de Vos WM
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):171-84. PubMed ID: 8775977
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis and mode of action of lantibiotics.
Chatterjee C; Paul M; Xie L; van der Donk WA
Chem Rev; 2005 Feb; 105(2):633-84. PubMed ID: 15700960
[No Abstract] [Full Text] [Related]
18. Bioengineering of the model lantibiotic nisin.
Field D; Cotter PD; Ross RP; Hill C
Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
[TBL] [Abstract][Full Text] [Related]
19. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
20. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.
Héchard Y; Sahl HG
Biochimie; 2002; 84(5-6):545-57. PubMed ID: 12423799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
